Pharmaceutical formulation

The invention relates to a pharmaceutical formulation comprising the Active Pharmaceutical Ingredient (3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically a...

Full description

Saved in:
Bibliographic Details
Main Authors LOWALEKAR, ROHIT, PAWAR, YOGESH, SAWAI, TUSHAR, REYNAUD, EMERIC, GURURAJAN, BINDHUMADHAVAN, ROGUE, VINCENT
Format Patent
LanguageChinese
English
Published 01.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a pharmaceutical formulation comprising the Active Pharmaceutical Ingredient (3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient, where, in particular, the pharmaceutical formulation is made by a process comprising wet granulation, direct compression or especially roller compaction, and related invention aspects disclosed herein.
Bibliography:Application Number: TW202312105963